A 12-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Citicoline as an Add-on Therapy Will be Conducted in 200 Outpatients With Bipolar I Disorder and Cocaine Dependence.
Phase of Trial: Phase IV
Latest Information Update: 26 Jan 2018
At a glance
- Drugs Citicoline (Primary)
- Indications Bipolar I disorders; Cocaine abuse
- Focus Therapeutic Use
- 30 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 May 2009 New trial record